AAAAAA

   
Results: 1-9 |
Results: 9
FETAL NEUROTRANSPLANTATION FOR PARKINSONS-DISEASE - RESULTS AFTER 8 YEARS
Authors: FREED CR BREEZE RE LEEHEY MA SCHNECK SA OBRIEN CF THOMPSON LL RAMIG LO MCRAE CA MAZZIOTTA JC MILETICH RS EIDELBERG D
Citation: Cr. Freed et al., FETAL NEUROTRANSPLANTATION FOR PARKINSONS-DISEASE - RESULTS AFTER 8 YEARS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 42-42
OPPORTUNITIES AND CHALLENGES IN ACADEMIC NEUROLOGY - REPORT OF THE LONG-RANGE PLANNING-COMMITTEE OF THE AMERICAN-NEUROLOGICAL-ASSOCIATION
Authors: GRIFFIN JW GRIGGS RC BARCHI R SCHNECK SA MOSES H PEDLEY T COLLINS RC FOLEY KM ROWLAND LP RINGEL S KONKOL RJ BOOSS J VISTE K PLEASURE D CASCINO TL CAPLAN L WOOTEN F MCDONALD R CHOI D MCARTHUR JC WAXMAN S YOUNG A PARRY G WHITAKER J PERCY A HANLEY D
Citation: Jw. Griffin et al., OPPORTUNITIES AND CHALLENGES IN ACADEMIC NEUROLOGY - REPORT OF THE LONG-RANGE PLANNING-COMMITTEE OF THE AMERICAN-NEUROLOGICAL-ASSOCIATION, Annals of neurology, 39(6), 1996, pp. 693-699
A NEW FRONTAL APPROACH FOR EMBRYONIC DOPAMINE CELL TRANSPLANTS FOR PARKINSONS-DISEASE
Authors: LEEHEY MA FREED CF BREEZE RE SCHNECK SA OBRIEN CF
Citation: Ma. Leehey et al., A NEW FRONTAL APPROACH FOR EMBRYONIC DOPAMINE CELL TRANSPLANTS FOR PARKINSONS-DISEASE, Neurology, 46(2), 1996, pp. 58003-58003
LACK OF A DETECTABLE-SYSTEMIC HUMORAL CELLULAR ALLOGENEIC RESPONSE INHUMAN AND NONHUMAN PRIMATE RECIPIENTS OF EMBRYONIC MESENCEPHALIC ALLOGRAFTS FOR THE THERAPY OF PARKINSONS-DISEASE
Authors: ANSARI AA MAYNE A FREED CR BREEZE RE SCHNECK SA OBRIEN CF KRIEK EH ZHANG YB MAZZIOTTA JC HUTCHINSON M SCHROTER G BAKAY RA BOYER K SUNDSTROM JB
Citation: Aa. Ansari et al., LACK OF A DETECTABLE-SYSTEMIC HUMORAL CELLULAR ALLOGENEIC RESPONSE INHUMAN AND NONHUMAN PRIMATE RECIPIENTS OF EMBRYONIC MESENCEPHALIC ALLOGRAFTS FOR THE THERAPY OF PARKINSONS-DISEASE, Transplantation proceedings, 27(1), 1995, pp. 1401-1405
TRANSPLANTATION OF FETAL MESENCEPHALIC TISSUE IN PARKINSONS-DISEASE
Authors: FREED CR BREEZE RE SCHNECK SA
Citation: Cr. Freed et al., TRANSPLANTATION OF FETAL MESENCEPHALIC TISSUE IN PARKINSONS-DISEASE, The New England journal of medicine, 333(11), 1995, pp. 730-731
ZOSTER SINE HERPETE, A CLINICAL VARIANT
Authors: GILDEN DH WRIGHT RR SCHNECK SA GWALTNEY JM MAHALINGAM R
Citation: Dh. Gilden et al., ZOSTER SINE HERPETE, A CLINICAL VARIANT, Annals of neurology, 35(5), 1994, pp. 530-533
IMMUNOSUPPRESSANTS MAY NOT IMPROVE TRANSPLANT SUCCESS AFTER HUMAN FETAL DOPAMINE CELL IMPLANTS FOR PARKINSONS-DISEASE
Authors: FREED CR BREEZE RE ROSENBERG NL SCHNECK SA OBRIEN CF KRIEK EH ZHANG YB MAZZIOTTA JC HUTCHINSON M HUANG SC ANSARI AA
Citation: Cr. Freed et al., IMMUNOSUPPRESSANTS MAY NOT IMPROVE TRANSPLANT SUCCESS AFTER HUMAN FETAL DOPAMINE CELL IMPLANTS FOR PARKINSONS-DISEASE, Neurology, 44(4), 1994, pp. 10000323-10000323
COMPOSITION AT THE AMERICAN-BOARD-OF-PSYCHIATRY-AND-NEUROLOGY - REPLY
Authors: SCHNECK SA
Citation: Sa. Schneck, COMPOSITION AT THE AMERICAN-BOARD-OF-PSYCHIATRY-AND-NEUROLOGY - REPLY, Archives of neurology, 51(9), 1994, pp. 849-849
CLINICAL NEUROPHYSIOLOGY EDUCATION IN RESIDENCY
Authors: SCHNECK SA
Citation: Sa. Schneck, CLINICAL NEUROPHYSIOLOGY EDUCATION IN RESIDENCY, Annals of neurology, 33(6), 1993, pp. 658-659
Risultati: 1-9 |